PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Pfizer (PFE) Misses Q4 EPS by 6c, Raises FY21 EPS Guidance
February 2, 2021 6:47 AM ESTPfizer (NYSE: PFE) reported Q4 EPS of $0.42, $0.06 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.43 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.10-$3.20, versus the consensus of $3.19. Pfizer sees... More
